VENLO (dpa-AFX) - Qiagen NV (QGEN) said that it entered into a binding agreement with Ipsogen S.A. co-founders Vincent Fert and Stéphane Debono, Ipsogen board member Kevin Rakin, Amundi Asset Management and Matignon Investissement relating to the unconditional purchase of their respective Ipsogen shares, which together amount to approximately 47% of the company's share capital.
Qiagen also has entered into agreements with other shareholders to purchase approximately additional 14% of Ipsogen's share capital.
Qiagen expects to complete these transactions to acquire this Ipsogen stake of approximately 61% on or about July 12, 2011. Upon completion of this step, Ipsogen would become a fully consolidated subsidiary of QIAGEN.
On June 15, 2011, QIAGEN announced it was in exclusive negotiations to purchase an initial stake in Ipsogen from these shareholders for €12.90 per share. QIAGEN announced at that time it would subsequently initiate a public tender offer for the remaining shares at the same price if the offer was accepted.
Copyright RTT News/dpa-AFX